NGL FINE CHEM LIMITED
NGLFINE · General/Diversified · NSE
₹2,502
Current Market Price
Under Review— We don’t have enough data to publish a fair value estimate for NGLFINE yet. Reason: Data Limited.
Updated just now
YieldIQ Score
—
Piotroski F-Score
6/9
Economic Moat
None
Confidence
25%
ROE
14.6%
Debt/Equity
0.33
WACC
11.1%
Market Cap
₹1,546 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
20.0%
Return on capital employed
EV / EBITDA
32.5×
Enterprise multiple
Debt / EBITDA
2.0×
Leverage vs earnings
Interest Coverage
12.9×
EBIT covers interest
Current Ratio
1.98×
Short-term liquidity
Asset Turnover
1.16×
Revenue per ₹ of assets
Revenue CAGR (3Y)
22.3%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
Ratio Trends
NGLFINE · last 5 annual periods
ROE
14.6%
ROCE
20.0%
Operating Margin
—
Debt / Equity
0.33×
PE
36.2×
EV / EBITDA
19.2×
Historical Financials
NGLFINE · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 yfinance | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹313 Cr | ₹274 Cr | ₹334 Cr | ₹368 Cr | ₹501 Cr | +12.5% |
| EBITDA | ₹78.5 Cr | ₹39.9 Cr | ₹67.4 Cr | ₹42.5 Cr | ₹87.4 Cr | +2.7% |
| EBIT | — | ₹28.6 Cr | ₹55.8 Cr | — | — | +18.2% |
| PAT | ₹49.9 Cr | ₹20.5 Cr | ₹41.3 Cr | ₹21.1 Cr | ₹48.1 Cr | -0.9% |
| EPS (diluted) | — | ₹33.18 | ₹66.88 | — | — | +19.2% |
| CFO | ₹13.8 Cr | ₹35.3 Cr | ₹20.5 Cr | ₹32.4 Cr | ₹43.3 Cr | +33.0% |
| CapEx | ₹-56.4 Cr | ₹-31.4 Cr | ₹-28.5 Cr | ₹-74.3 Cr | ₹-89.9 Cr | — |
| FCF | ₹-42.6 Cr | ₹3.9 Cr | ₹-8.1 Cr | ₹-41.9 Cr | ₹-46.5 Cr | — |
| Total Assets | ₹277 Cr | ₹287 Cr | ₹356 Cr | ₹433 Cr | ₹545 Cr | +18.5% |
| Total Debt | ₹30.0 Cr | ₹32.5 Cr | ₹34.0 Cr | ₹77.1 Cr | ₹109 Cr | +37.9% |
| Shareholders' Equity | ₹203 Cr | ₹223 Cr | ₹263 Cr | ₹282 Cr | ₹329 Cr | +12.8% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
NGLFINE vs 4 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 TTKHLTCARE TTKHLTCARE | — | — | Pending | 7.7% | — |
SAIPARENT SAIPARENT | — | — | Pending | 15.9% | — |
SMSPHARMA SMSPHARMA | — | — | Pending | 10.8% | — |
SENORES SENORES | — | — | Pending | 7.2% | — |
Click a ticker to view its fair-value analysis.
Dividend History
3 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹5.25/sh
Last payout
2025-08-12
₹1.75
Peak payout
₹1.75
Trailing yield
0.07%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
Risk Analysis
Volatility & drawdown
Risk profile of NGLFINE →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for NGLFINE →
Compare
Head-to-head with peers
Compare NGLFINE side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse NGLFINENow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.